We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Shionogi aims to double flu-drug market with FDA-approved treatment
United Kingdom News News
TOKYO: Japan's Shionogi & Co Ltd aims to double the global market for flu treatment with its drug Xofluza, the first flu drug approved by the U.S.